End of Content.
SARS-CoV-2 RNA Qualitative
Overview
The SARS-CoV-2 RNA Qualitative test detects the presence of SARS-CoV-2 RNA in patient samples. Utilizing Real-Time Reverse Transcription Polymerase Chain Reaction (RT-qPCR), this test confirms COVID-19 infection, aiding in patient diagnosis and disease management. It is particularly crucial for early detection of the virus, even in asymptomatic individuals, facilitating timely isolation and contact tracing efforts. The test’s sensitivity and specificity make it a cornerstone in the global response to the COVID-19 pandemic, enabling effective public health interventions and control measures.
Frequently Asked Questions
The SARS-CoV-2 RNA Qualitative test is a diagnostic assay that detects the presence of SARS-CoV-2 ribonucleic acid (RNA) in patient samples, confirming COVID-19 infection.
It is performed to diagnose COVID-19 infection, especially in individuals with symptoms suggestive of the disease or those who have had close contact with confirmed cases.
The test is highly accurate when performed correctly, with a high sensitivity and specificity for detecting SARS-CoV-2 RNA in patient samples.
Respiratory specimens such as nasopharyngeal swabs, nasal swabs, or oropharyngeal swabs are commonly used for the test.
False-negative results may occur if the viral load is low or if the specimen is collected too early or too late after exposure. Proper specimen collection and handling are crucial for accurate results.
Why OrbitoAsia Diagnostics?
Orbito Asia Labs and Scans is a comprehensive healthcare imaging and diagnostic facility under one roof. It prides itself on providing the most advanced infrastructure, the best possible medical facilities, the most competitive prices, and thorough individualised attention so that the customer can have diagnostic tests performed in the most efficient and cost-effective manner at a single location by our experienced and certified physicians and friendly staff.
